MedPath

Community-Based Engagement to Improve Lung Cancer Screening and Outcomes

Not Applicable
Not yet recruiting
Conditions
Lung Cancer Screening
Registration Number
NCT06909981
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

The goal of this pilot study is to understand the impact of a mobile lung cancer screening clinics in individuals from neighborhoods and communities with less access to resources in Boston, Massachusetts who are at high risk for lung cancer. The main questions it aims to answer includes:

* Is mobile lung cancer screening is feasible and acceptable?

* Is collecting social needs data during the mobile lung cancer screening clinics feasible?

Participants will:

* Complete an intake survey, providing information about their demographic, medical, and social needs information.

* Undergo a shared decision-making conversation to determine whether lung cancer screening should be done.

* Undergo lung cancer screening.

* Undergo a debriefing conversation and fill out an acceptability survey.

* Undergo a semi-structured phone interview between four and eight weeks after lung cancer screening date.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Ability to understand and the willingness to sign a written informed consent document prior to any study-related procedures.
  • Willing to undergo treatment.
  • Adults between the ages of 50 and 80 years.
  • No recent CT or MRI imaging within the last year.
  • Currently smokes tobacco or has quit smoking tobacco within the past 15 years.
  • Has a tobacco smoking history of at least 20 pack years (i.e. one pack per day for the last 20 years or equivalent).
  • Has never been diagnosed with lung cancer.
Exclusion Criteria
  • Adults/children less than 50 years, or greater than 80 years of age.
  • Has never smoked tobacco.
  • Has smoked tobacco but quit more than 15 years ago.
  • Has a tobacco smoking history of less than 20 pack years.
  • Presence of major comorbidity(ies) that could prevent treatment.
  • Previous diagnosis of lung cancer.
  • In the opinion of the investigator, the subject is not an appropriate candidate for the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Feasibility of mobile lung cancer screening in target communities in Boston, Massachusetts.During the intervention.

This outcome will be assessed by calculating the raw count of individuals screened at each mobile clinic and the number of individuals unable to be screened due to time constraints.

Acceptability of mobile lung cancer screening in target communities in Boston, Massachusetts.Between four and eight weeks after the intervention

Acceptability will be assessed using semi-structured phone interviews with participants. Responses to questions, themes, and keywords will be analyzed to report attitudes regarding the intervention.

Secondary Outcome Measures
NameTimeMethod
Feasibility of collecting social determinants of health data during mobile lung cancer screening clinics in underserved communities in Boston, Massachusetts.Pre-intervention

Feasibility will be measured using the raw count of completed intake surveys.

© Copyright 2025. All Rights Reserved by MedPath